SIGLEC1 and lymphoma: These CD169+ cells were also positive for CD14 (monocyte/macrophage marker), and it has been hypothesized that the CD169+/CD14+ cells observed in the splenic cords of splenic marginal zone lymphomas might have a dendritic cell differentiation potential [96].